Title : E2F1 downregulation by arsenic trioxide in lung adenocarcinoma.

Pub. Date : 2014 Nov

PMID : 25174355






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 E2F1 downregulation by arsenic trioxide in lung adenocarcinoma. Arsenic Trioxide E2F transcription factor 1 Homo sapiens
2 Using the H358 xenograft model, the tumor growth was suppressed in the ATO treatment group during 8 days of treatment, associated with downregulation of E2F1 and upregulation of truncated Bid and cleaved caspase-3. Arsenic Trioxide E2F transcription factor 1 Homo sapiens
3 In conclusion, ATO has potent in vitro and in vivo activity in lung adenocarcinoma, partially mediated through E2F1 downregulation and apoptosis. Arsenic Trioxide E2F transcription factor 1 Homo sapiens